These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 28926589)

  • 1. Meta-analysis of promoter methylation in eight tumor-suppressor genes and its association with the risk of thyroid cancer.
    Khatami F; Larijani B; Heshmat R; Keshtkar A; Mohammadamoli M; Teimoori-Toolabi L; Nasiri S; Tavangar SM
    PLoS One; 2017; 12(9):e0184892. PubMed ID: 28926589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RASSF1A promoter methylation is associated with increased risk of thyroid cancer: a meta-analysis.
    Shou F; Xu F; Li G; Zhao Z; Mao Y; Yang F; Wang H; Guo H
    Onco Targets Ther; 2017; 10():247-257. PubMed ID: 28123306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PTEN, RASSF1 and DAPK site-specific hypermethylation and outcome in surgically treated stage I and II nonsmall cell lung cancer patients.
    Buckingham L; Penfield Faber L; Kim A; Liptay M; Barger C; Basu S; Fidler M; Walters K; Bonomi P; Coon J
    Int J Cancer; 2010 Apr; 126(7):1630-9. PubMed ID: 19795445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations of RASSF1A, RARβ, and CDH1 promoter hypermethylation with oral cancer risk: A PRISMA-compliant meta-analysis.
    Wen G; Wang H; Zhong Z
    Medicine (Baltimore); 2018 Mar; 97(11):e9971. PubMed ID: 29538221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salivary DNA Methylation as an Epigenetic Biomarker for Head and Neck Cancer. Part II: A Cancer Risk Meta-Analysis.
    Rapado-González Ó; Martínez-Reglero C; Salgado-Barreira Á; Santos MA; López-López R; Díaz-Lagares Á; Suárez-Cunqueiro MM
    J Pers Med; 2021 Jun; 11(7):. PubMed ID: 34206840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promoter hypermethylation of RARβ2, DAPK, hMLH1, p14, and p15 is associated with progression of breast cancer: A PRISMA-compliant meta-analysis.
    Qi M; Xiong X
    Medicine (Baltimore); 2018 Dec; 97(51):e13666. PubMed ID: 30572486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between p16 Promoter Methylation and Thyroid Cancer Risk: A Meta-analysis.
    Wu W; Yang SF; Liu FF; Zhang JH
    Asian Pac J Cancer Prev; 2015; 16(16):7111-5. PubMed ID: 26514498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Qualitative and quantitative promoter hypermethylation patterns of the P16, TSHR, RASSF1A and RARβ2 genes in papillary thyroid carcinoma.
    Mohammadi-asl J; Larijani B; Khorgami Z; Tavangar SM; Haghpanah V; Kheirollahi M; Mehdipour P
    Med Oncol; 2011 Dec; 28(4):1123-8. PubMed ID: 20535589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between BRAF mutation and promoter methylation of TIMP3, RARβ2 and RASSF1A in thyroid cancer.
    Brait M; Loyo M; Rosenbaum E; Ostrow KL; Markova A; Papagerakis S; Zahurak M; Goodman SM; Zeiger M; Sidransky D; Umbricht CB; Hoque MO
    Epigenetics; 2012 Jul; 7(7):710-9. PubMed ID: 22694820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of CDH1 promoter methylation in colorectal carcinogenesis: a meta-analysis.
    Li YX; Lu Y; Li CY; Yuan P; Lin SS
    DNA Cell Biol; 2014 Jul; 33(7):455-62. PubMed ID: 24684676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association between CDH1 promoter methylation and patients with ovarian cancer: a systematic meta-analysis.
    Wang Q; Wang B; Zhang YM; Wang W
    J Ovarian Res; 2016 Apr; 9():23. PubMed ID: 27067410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypermethylation of RARβ2 correlates with high COX-2 expression and poor prognosis in patients with colorectal carcinoma.
    Miladi-Abdennadher I; Abdelmaksoud-Damak R; Ayadi L; Khabir A; Frikha F; Kallel L; Amouri A; Frikha M; Sellami-Boudawara T; Gargouri A; Mokdad-Gargouri R
    Tumour Biol; 2010 Oct; 31(5):503-11. PubMed ID: 20571967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Germline promoter hypermethylation of tumor suppressor genes in gastric cancer.
    Wu PY; Zhang Z; Wang JM; Guo WW; Xiao N; He Q; Wang YP; Fan YM
    World J Gastroenterol; 2012 Jan; 18(1):70-8. PubMed ID: 22228973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Promoter hypermethylation of the tumor-suppressor genes RASSF1A, GSTP1 and CDH1 in endometrial cancer.
    Fiolka R; Zubor P; Janusicova V; Visnovsky J; Mendelova A; Kajo K; Lasabova Z; Plank L; Danko J
    Oncol Rep; 2013 Dec; 30(6):2878-86. PubMed ID: 24068440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of CDH1 promoter polymorphism and DNA methylation in bladder carcinogenesis: a meta-analysis.
    Wang Y; Kong CZ; Zhang Z; Yang CM; Li J
    DNA Cell Biol; 2014 Apr; 33(4):205-16. PubMed ID: 24491043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methylation of tumour suppressor genes associated with thyroid cancer.
    Botezatu A; Iancu IV; Plesa A; Manda D; Popa O; Bostan M; Mihaila M; Albulescu A; Fudulu A; Vladoiu SV; Huica I; Dobrescu R; Anton G; Badiu C
    Cancer Biomark; 2019; 25(1):53-65. PubMed ID: 31006665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical significance of detection of tumor suppressor genes aberrant methylation in cervical carcinoma tissue].
    Xu J; Wang HL; Lu GC; Wang ZJ; Lin X; Zhou HW
    Zhonghua Fu Chan Ke Za Zhi; 2007 Jun; 42(6):394-7. PubMed ID: 17697601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between TSHR gene methylation and papillary thyroid cancer: a meta-analysis.
    Qu M; Wan S; Ren B; Wu H; Liu L; Shen H
    Endocrine; 2020 Sep; 69(3):508-515. PubMed ID: 32279226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CpG island promoter methylation (CIHM) status of tumor suppressor genes correlates with morphological appearances of gastric cancer.
    Tahara T; Shibata T; Arisawa T; Nakamura M; Yamashita H; Yoshioka D; Okubo M; Yonemura J; Maeda Y; Maruyama N; Kamano T; Kamiya Y; Fujita H; Nakagawa Y; Nagasaka M; Iwata M; Hirata I
    Anticancer Res; 2010 Jan; 30(1):239-44. PubMed ID: 20150642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cigarette Smoking, BPDE-DNA Adducts, and Aberrant Promoter Methylations of Tumor Suppressor Genes (TSGs) in NSCLC from Chinese Population.
    Jin Y; Xu P; Liu X; Zhang C; Tan C; Chen C; Sun X; Xu Y
    Cancer Invest; 2016; 34(4):173-80. PubMed ID: 27042875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.